Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IDH Wild Type Glioblastoma”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Not applicableLooking for participantsNCT06273176
What this trial is testing

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme of Brain+6 more
Erasmus Medical Center 225
Not applicableLooking for participantsNCT06160596
What this trial is testing

Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis

Who this might be right for
Pancreas AdenocarcinomaSmall-cell Lung CancerGlioblastoma, IDH-wildtype
Cure 51 1,020
Large-scale testing (Phase 3)Looking for participantsNCT07452458
What this trial is testing

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Who this might be right for
Glioblastoma, IDH-WildtypeMGMT-Unmethylated Glioblastoma
NRG Oncology 398
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Early research (Phase 1)Looking for participantsNCT06455605
What this trial is testing

D2C7-IT + 2141-V11 Combination Post-resection in rGBM

Who this might be right for
Recurrent Glioblastoma IDH Wildtype
Darell Bigner 46
Testing effectiveness (Phase 2)Looking for participantsNCT06327451
What this trial is testing

Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtype
Tianjin Medical University General Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07301268
What this trial is testing

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Who this might be right for
Glioblastoma, IDH-WildtypeProgressive Astrocytoma, IDH-Mutant, Grade 4Progressive Glioblastoma+6 more
Mayo Clinic 36
Not applicableLooking for participantsNCT05326334
What this trial is testing

THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)

Who this might be right for
Glioblastoma, IDH-wildtype
Ottawa Hospital Research Institute 20
Early research (Phase 1)Active Not RecruitingNCT05236036
What this trial is testing

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Who this might be right for
AstrocytomaGlioblastomaGlioblastoma, IDH-Wildtype+2 more
Northwestern University 86
Early research (Phase 1)Looking for participantsNCT06641908
What this trial is testing

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 65
Not applicableNot Yet RecruitingNCT07788430
What this trial is testing

Impact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical Study

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Institut Claudius Regaud 120
Testing effectiveness (Phase 2)WithdrawnNCT06328036
What this trial is testing

Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07604285
What this trial is testing

Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma
Myosin Therapeutics Inc. 36
Early research (Phase 1)Study completedNCT04757662
What this trial is testing

Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma

Who this might be right for
Grade III AstrocytomaGrade IV AstrocytomaAstrocytoma, Grade IV+1 more
Washington University School of Medicine 18
Very early researchLooking for participantsNCT06552260
What this trial is testing

A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

Who this might be right for
GlioblastomaRecurrent GlioblastomaBrain Tumor
Ugonma Chukwueke 27
Testing effectiveness (Phase 2)Looking for participantsNCT03649880
What this trial is testing

Feasibility of FMISO in Brain Tumors

Who this might be right for
IDH Wild Type Glioblastoma
OHSU Knight Cancer Institute 77
Testing effectiveness (Phase 2)Looking for participantsNCT04623931
What this trial is testing

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Who this might be right for
Anaplastic Astrocytoma, IDH-WildtypeAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+6 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06258018
What this trial is testing

Niraparib and Temozolomide in Patients Glioblastoma

Who this might be right for
Glioma, Malignant
Armando Santoro, MD 86
Testing effectiveness (Phase 2)Looking for participantsNCT05864534
What this trial is testing

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Who this might be right for
Newly Diagnosed GlioblastomaGlioblastoma, Isocitric Dehydrogenase (IDH)-WildtypeGliosarcoma+1 more
Northwestern University 25
Early research (Phase 1)Looking for participantsNCT06860594
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Who this might be right for
Astrocytoma, IDH-Mutant, Grade 2Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Adult Diffuse Midline Glioma, H3 K27-Mutant+4 more
National Cancer Institute (NCI) 30
Next Page